George Kemble
Vermögen: 616 637 $ am 31.10.2026
Vermögen: 616 637 $ am 31.10.2026
George W.
Kemble is Executive Chairman at Sagimet Biosciences, Inc. since 2022.
Formerly, Dr. Kemble was Senior Vice President-Research & Development at MedImmune LLC from 2001 to 2011.
Other former roles include Director at LigoCyte Pharmaceuticals, Inc. and Staff Scientist at MedImmune Vaccines, Inc. Education includes a doctorate from Stanford University and an undergraduate degree from Santa Clara University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 14.08.2026 | 62’161 ( 0.09% ) | 616 637 $ | 31.10.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| SAGIMET BIOSCIENCES INC. | Vorsitzender | 24.10.2022 |
| Unternehmen | Position | Ende |
|---|---|---|
MedImmune LLC
MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2011 |
MedImmune Vaccines, Inc.
MedImmune Vaccines, Inc. BiotechnologyHealth Technology Develops, manufactures and markets live vaccines | Corporate Officer/Principal | - |
LigoCyte Pharmaceuticals, Inc.
LigoCyte Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Developed vaccines and monoclonal antibody therapeutics | Direktor/Vorstandsmitglied | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 6 |
|---|---|
MedImmune LLC
MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
MedImmune Vaccines, Inc.
MedImmune Vaccines, Inc. BiotechnologyHealth Technology Develops, manufactures and markets live vaccines | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Santa Clara University
Santa Clara University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
LigoCyte Pharmaceuticals, Inc.
LigoCyte Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Developed vaccines and monoclonal antibody therapeutics | Health Technology |
Sagimet Biosciences, Inc.
Sagimet Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel therapeutics for the treatment of infectious diseases | Health Technology |
Bitte wählen Sie Ihre Edition
Alle länderspezifischen Finanzinformationen